HIV-exposed infants
Showing 1 - 25 of >10,000
Hiv, Vaccine Reaction, Microbial Colonization Trial (B. infantis Rosell®-33, Placebo)
Not yet recruiting
- Hiv
- +3 more
- B. infantis Rosell®-33
- Placebo
- (no location specified)
Jun 19, 2023
HIV, Infant Morbidity, Breast Feeding Trial in Stellenbosch (Synbiotic, Maltodextrin)
Recruiting
- HIV
- +2 more
- Synbiotic
- Maltodextrin
-
Stellenbosch, Western Cape, South AfricaWorcester Campus of Stellenbosch University (SU)
Oct 10, 2022
Severe Illness, Septicaemia, Diarrhoea Trial in Kampala (BCG at birth, Control arm: Delayed BCG)
Recruiting
- Severe Illness
- +3 more
- BCG at birth
- Control arm: Delayed BCG
-
Kampala, UgandaHealth Centers in Mukono and Kampala districts
Aug 24, 2022
HIV Trial in Johannesburg (CH505TF gp120, GLA-SE adjuvant, Placebo)
Recruiting
- HIV Infections
- CH505TF gp120
- +2 more
-
Johannesburg, Gauteng, South AfricaPerinatal HIV Research Unit (PHRU), Soweto CRS
Apr 29, 2022
Diphtheria, Tetanus, Pertussis Trial in Soweto (Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine)
Completed
- Diphtheria
- +5 more
- Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine
-
Soweto, South Africa(unnamed)
Mar 24, 2022
Pneumonia, Pneumocystis Carinii, HIV Trial in Puerto Rico, United States (Atovaquone)
Completed
- Pneumonia, Pneumocystis Carinii
- HIV Infections
-
San Francisco, California
- +5 more
Oct 27, 2021
HIV/AIDS, Infant Morbidity, Pediatric HIV Infection Trial in Nairobi, Harare (Point of Care Early Infant Diagnosis, Standard of
Completed
- HIV/AIDS
- +3 more
- Point of Care Early Infant Diagnosis
- Standard of Care Early Infant Diagnosis
-
Nairobi, Kenya
- +1 more
Feb 3, 2021
HIV Trial in Gaborone (Point-of-Care Cepheid Xpert HIV-1, DTG/ABC/3TC)
Recruiting
- HIV
- Point-of-Care Cepheid Xpert HIV-1
- DTG/ABC/3TC
-
Gaborone, BotswanaBotswana Harvard HIV/AIDS Institute Partnership
Jul 5, 2022
HIV, Insulin Sensitivity, Diabetes Trial in Gaborone (Zidovudine, Nevirapine)
Completed
- HIV
- +2 more
-
Gaborone, BotswanaBotswana-Harvard AIDS Institute Partnership
Jul 18, 2022
HIV Trial in Worldwide (Dolutegravir 0.5 mg/kg oral suspension, Dolutegravir 5 mg Dispersible Tablets)
Recruiting
- HIV
- Dolutegravir 0.5 mg/kg oral suspension
- Dolutegravir 5 mg Dispersible Tablets
-
Los Angeles, California
- +17 more
Nov 10, 2022
Substance Use Disorders, HIV Trial (Virtual Reality Tool)
Not yet recruiting
- Substance Use Disorders
- HIV Infections
- Virtual Reality Tool
- (no location specified)
Apr 13, 2023
Mother-Child Relations, Substance Use Trial in Surrey, Toronto (Breaking the Cycle Program, Maxxine Wright Program)
Not yet recruiting
- Mother-Child Relations
- Substance Use
- Breaking the Cycle Program
- Maxxine Wright Program
-
Surrey, British Columbia, Canada
- +1 more
Mar 3, 2023
Predict NEOnatal Acute Kidney Injury in Newborns expoSed to
Not yet recruiting
- Acute Kidney Injury
- +7 more
-
Milan, MI, ItalyNeonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda, Osped
May 5, 2023
Transmission of Impaired Glucose Metabolism in Infants Exposed
Completed
- Pregnancy
- Gestational Diabetes Mellitus
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Jun 8, 2022
Group B Streptococcal Infection Trial in Kawempe (GBS6)
Recruiting
- Group B Streptococcal Infection
-
Kawempe, UgandaMakerere University, John Hopkins University
Apr 14, 2023
Microbial Colonization Trial (Donor Human Milk - Nutritional Replacement)
Not yet recruiting
- Microbial Colonization
- Donor Human Milk - Nutritional Replacement
- (no location specified)
Apr 14, 2023
Antiretroviral and Related Drugs in Lactating Women and
Not yet recruiting
- Lactating Women on Select DOI
- +2 more
- Dolutegravir
- +3 more
-
Botswana, Gaborone, South Africa
- +3 more
Jan 19, 2023
Risk for an Alcohol-Exposed Pregnancy, Risk for Marijuana-Exposed Pregnancy, Risk for Substance-Exposed Pregnancy Trial in
Recruiting
- Risk for an Alcohol-Exposed Pregnancy
- +4 more
- CHOICES-TEEN
- Health and Life Skills Education
-
Houston, TexasBaylor University
May 6, 2022